Welcome to LookChem.com Sign In|Join Free
  • or
5-ethyl-4-hydroxyisophthalaldehyde is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

125895-96-7

Post Buying Request

125895-96-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

125895-96-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 125895-96-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,8,9 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 125895-96:
(8*1)+(7*2)+(6*5)+(5*8)+(4*9)+(3*5)+(2*9)+(1*6)=167
167 % 10 = 7
So 125895-96-7 is a valid CAS Registry Number.

125895-96-7Relevant academic research and scientific papers

Hybrid benzofuran-bisindole derivatives: New prototypes with promising anti-hyperlipidemic activities

Sashidhara, Koneni V.,Modukuri, Ram K.,Sonkar, Ravi,Rao, K. Bhaskara,Bhatia, Gitika

, p. 38 - 46 (2013)

A series of different benzofuran-bisindole hybrids were synthesized and evaluated in vitro for their antioxidant and in vivo for antidyslipidemic activity in triton WR-1339 induced hyperlipidemic rats. Among the series, compounds 4a, 4c, 4h and 4j showed

Discovery of coumarin-dihydroquinazolinone analogs as niacin receptor 1 agonist with in-vivo anti-obesity efficacy

Singh, L. Ravithej,Kumar, Ajeet,Upadhyay, Akanksha,Gupta, Sampa,Palanati, Gopala Reddy,Sikka, Kamakshi,Siddiqi, Mohammad Imran,Yadav, Prem N.,Sashidhara, Koneni V.

supporting information, p. 208 - 222 (2018/05/14)

In this study, we presented rational designing and synthesis of coumarin-dihydroquinazolinone conjugates to evaluate their agonist activity at GPR109a receptor. Among the synthesized small molecule library, compound 10c displayed robust agonist action at

Synthesis and study of benzofuran-pyran analogs as BMP-2 targeted osteogenic agents

Kushwaha, Pragati,Tripathi, Ashish Kumar,Gupta, Sampa,Kothari, Priyanka,Upadhyay, Akanksha,Ahmad, Naseer,Sharma, Tanuj,Siddiqi,Trivedi, Ritu,Sashidhara, Koneni V.

, p. 103 - 117 (2018/07/06)

Twenty-four novel benzofuran-pyran derivatives were synthesized and evaluated for their anti-osteoporotic activity in primary cultures of rat calvarial osteoblasts in vitro. Among all the compounds screened for the alkaline phosphatase activity, three compounds 4e, 4j and 4k showed potent activity at picomolar concentrations in osteoblast differentiating stimulation. Additionally, these compounds were found effective in mineralization, assessed by alizarin red-S staining assay. Compounds were again validated through a series of other in vitro experiments. Moreover, molecular dynamics simulations demonstrated that both benzofuran and pyran moieties are requisite to fit into the active site of BMP-2 receptor, a key target of the osteogenic agents. The obtained results strongly convey that compound 4e is a potential bone anabolic agent among synthesized series, which can be further explored as a drug lead for treating osteoporosis.

Benzofuran-pyran hybrids: A new class of potential bone anabolic agents

Gupta, Sampa,Adhikary, Sulekha,Modukuri, Ram K.,Choudhary, Dharmendra,Trivedi, Ritu,Sashidhara, Koneni V.

supporting information, p. 1719 - 1724 (2018/05/04)

Benzofuran moiety is an important pharmacophore showing positive effects on bone health. In the present study, sixteen benzofuran-pyran hybrids were synthesized and were evaluated for their osteogenic effects on primary osteoblast cells isolated from calv

Benzofuran-dihydropyridine hybrids: A new class of potential bone anabolic agents

Modukuri, Ram K.,Choudhary, Dharmendra,Gupta, Sampa,Rao, K. Bhaskara,Adhikary, Sulekha,Sharma, Tanuj,Siddiqi, Mohammad Imran,Trivedi, Ritu,Sashidhara, Koneni V.

, p. 6450 - 6466 (2017/11/09)

A series of novel benzofuran-dihydropyridine hybrids were designed by molecular hybridization approach and evaluated for bone anabolic activities. Among the screened library, ethyl 4-(7-(sec-butyl)-2-(4-methylbenzoyl)benzofuran-5-yl)-2-methyl-5-oxo-1,4,5,

Designing, synthesis of selective and high-affinity chalcone-benzothiazole hybrids as Brugia malayi thymidylate kinase inhibitors: In vitro validation and docking studies

Sashidhara, Koneni V.,Avula, Srinivasa Rao,Doharey, Pawan Kumar,Singh, L. Ravithej,Balaramnavar, Vishal M.,Gupta, Jyoti,Misra-Bhattacharya, Shailja,Rathaur, Sushma,Saxena, Anil K.,Saxena, Jitendra Kumar

, p. 418 - 428 (2015/09/28)

In our continuing search for safe and efficacious antifilarials, a series of novel chalcone-benzothiazole hybrids have been synthesized and evaluated for their Brugia malayi thymidylate kinase (BmTMK) enzyme inhibition activity. Their selectivity towards BmTMK was studied and compared to the human TMK (HsTMK) by an in silico method. Out of seventeen derivatives, compounds 34 and 42 showed higher interactions with the BmTMK active site. MolDock docking model revealed the interactions of these two derivatives and the results corroborated well with their in vitro antifilarial activities. Our studies suggest that these hybrids are selective towards the BmTMK enzyme and may serve as potential therapeutic agents against filariasis.

A new iodine catalyzed regioselective synthesis of xanthene synthons

Sashidhara, Koneni V.,Kumar, Abdhesh,Dodda, Ranga Prasad,Kumar, Bikash

supporting information; experimental part, p. 3281 - 3283 (2012/07/31)

This Letter describes the iodine catalyzed one-pot regioselective synthesis of p-condensed xanthenes as our key point of transformation, which provides an efficient access to five skeletally diverse scaffolds in excellent yields.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 125895-96-7